AbbVie

AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs. Read more

57,857 Followers on Owler
57,857 Followers on Owler
57,857 Followers on Owler
57,857 Followers on Owler

AbbVie

AbbVie discovers, develops and markets both biopharmaceuticals and small molecule drugs. Read more

Richard A. Gonzalez's photo - Chairman & CEO of AbbVie

Chairman & CEO

Richard A. Gonzalez

CEO Approval Rating

85/100

Founded:

2013

Status:

PublicIndependent CompanyNYSEABBV

ABBVIE TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Amgen is the top competitor of AbbVie. Amgen was founded in 1980, and its headquarters is in Thousand Oaks, California. Amgen is in the Biotechnology field. Amgen has 5,700 fewer employees than AbbVie.

Novo Nordisk is seen as one of AbbVie's top competitors. Novo Nordisk was founded in Bagsvaerd, Capital Region} in 1923. Like AbbVie, Novo Nordisk also works within the Pharmaceuticals industry. Compared to AbbVie, Novo Nordisk generates $24.8B less revenue.

GSK is AbbVie's #3 rival. GSK's headquarters is in Middlesex, England, and was founded in 2000. Like AbbVie, GSK also competes in the Pharmaceuticals sector. GSK generates 101% of AbbVie's revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Novartis a competitor of AbbVie?

AbbVie Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$45.8B

AbbVie's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 31.9B. Over the last four quarters, AbbVie's revenue has grown by 60.8%. Specifically, in Q4 2020's revenue was $13.9B; in Q3 2020, it was $12.9B; in Q2 2020, it was $10.4B; in Q1 2020, AbbVie's revenue was $8.6B.

AbbVie Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Mavupharma

Jul 2019

Source »
undisclosed
Mavupharma is a drug discovery company that discovers and develops novel therapeutics for the treatment of cancer and infectious disease.
Allergan plc

Jun 2019

Source »
$63B
Allergan designs, manufactures and commercializes pharmaceutical device and surgical and regenerative medicine products for patients.

-

Cystic Fibrosis Business, Galapagos

Oct 2018

Source »
$45M
-
Stem CentRx, Inc.

Apr 2016

Source »
$5.8B
Stemcentrx researches, discovers, develops and commercializes therapies that cure and improve survival for cancer patients.
Pharmacyclics, LLC

Mar 2015

Source »
$21B
Pharmacyclics is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer and immune mediated diseases

These are all the companies that AbbVie has acquired. AbbVie has acquired 5 companies and its latest acquisition was Mavupharma in Jul 2019. Mavupharma is a drug discovery company that discovers and develops novel therapeutics for the treatment of cancer and infectious disease.

AbbVie Funding History

Since AbbVie was founded in 2013, it has participated in 1 round of funding. In total AbbVie has raised $6.0B. AbbVie's funding round was on Jul 2019 for a total of $6.0B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2019
$6B
-

Since AbbVie was founded in 2013, it has participated in 1 round of funding. In total AbbVie has raised $6.0B. AbbVie's funding round was on Jul 2019 for a total of $6.0B

AbbVie Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Quench Bio is a biotechnology company that develops and commercializes novel medicines for the treatment of inflammatory diseases.
$50M
Jan 26, 2020
Series A
-
Ribon Therapeutics develops small molecule inhibitors for the treatment of cancer.
$65M
Jan 03, 2019
Series B
-
PACT Pharma is a California-based clinical-stage biopharmaceutical company that develops T-cell therapies to treat patients with solid tumors.
$95.5M
May 14, 2018
Series B
-
Rodeo is a Washington-based pharmaceutical company that researches and develops small-molecular therapeutics for the treatment of inflammatory bowel diseases.
$5.9M
Jul 24, 2017
Series A
-
Aquinnah develops ribonucleic acid-binding proteins for the treatment of neurodegenerative diseases.
$10M
Apr 24, 2017
Equity
-

These are all the companies that AbbVie has invested in. AbbVie has invested 5 companies and its latest investment was Mavupharma in Jul 2019. Mavupharma is a drug discovery company that discovers and develops novel therapeutics for the treatment of cancer and infectious disease.

AbbVie News

May 10, 2021Pharamceutical Technology

AbbVie's IT hiring activity increases 8.8% in April 2021

US-based company AbbVie's IT hiring increased 8.8% in April 2021 when compared with the previous mont... See more »
May 5, 2021Romania Insider

US biotech startup gets USD 140 mln financing to advance groundbreaking research started by Romanian professor at Caltech

Capsida Biotherapeutics Inc., a US biotechnology startup using an adeno-associated virus (AAV) engine... See more »
April 30, 2021The Pharma Letter

AbbVie's shares rise as 1st-qtr financials beat expectations

US drugmaker AbbVie's shares rose as much as 2% pre-market today, after it announced financial result... See more »
April 30, 2021Markets Insider

AbbVie Reports First-Quarter 2021 Financial Results

NORTH CHICAGO, Ill., April 30, 2021 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results fo... See more »
April 30, 2021FiercePharma

Amid JAK safety uncertainty, AbbVie says latest data support its key launch Rinvoq

Amid JAK safety uncertainty, AbbVie says latest data support its key launch Rinvoq nhigginsdunn Fri, ... See more »

AbbVie Press Releases

March 22, 2021NewsFile

Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV

New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on beha... See more »
March 3, 2021Business Wire

Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline

BERKELEY, Calif.--(BUSINESS WIRE)--Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome ... See more »
February 10, 2021PR Newswire

BOTOX (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition

NORTH CHICAGO, Ill., Feb. 10, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today an... See more »
February 8, 2021Cision

SMC Issues Positive Decision for Treatment with AbbVie's RINVOQ[](upadacitinib) in Severe Active Rheumatoid Arthritis (RA)

· Positive indication means upadacitinib will be available to those with previously treated severe... See more »
January 15, 2021PR Newswire

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

NORTH CHICAGO, Ill., Jan. 15, 2021 /PRNewswire/ -- Allergan Aesthetics and Allergan, an AbbVie compan... See more »
January 12, 2021StreetInsider

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET Immunotherapy Drug Candidate

Dragonfly to receive payment for the first Opt-In from AbbVie as part of a multi-target collaboration... See more »

AbbVie Videos

Social Media

AbbVie Headquarters

1 North Waukegan Road

North Chicago, Illinois60064

1-847-932-7900

Driving Directions »

Trending Companies

AbbVie Summary

ABOUT

Overview

AbbVie, Inc. (NYSE: ABBV) is engaged in the development, production, manufacture, and sale of pharmaceutical products. It is a research-based pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and chemically-synthesiz...

CEO

AbbVie's Chairman & CEO, Richard A. Gonzalez, currently has an approval rating of 85%. AbbVie's primary competitors are Amgen, Novo Nordisk & GSK.

Website

abbvie.com

Frequently Asked Questions about AbbVie

  1. When was AbbVie founded?

    AbbVie was founded in 2013
  2. Who is AbbVie's CEO?

    AbbVie's CEO is Richard A. Gonzalez
  3. How much revenue does AbbVie generate?

    AbbVie generates $45.8B in revenue
  4. How much funding does AbbVie have?

    AbbVie has historically raised $6B in funding
  5. Where is AbbVie's headquarters?

    AbbVie's headquarters is in North Chicago Illinois, USA
  1. How many employees does AbbVie have?

    AbbVie has 30,000 employees
  2. What sector does AbbVie operate in?

    AbbVie is in Pharmaceuticals
  3. Who are AbbVie's competitors?

    AbbVie's top competitors are Amgen, Novo Nordisk, GSK
  4. Who has AbbVie invested in?

    AbbVie's has invested in companies such as Quench Bio, Ribon Therapeutics, PACT Pharma